STOCK TITAN

Baxter International Inc. - BAX STOCK NEWS

Welcome to our dedicated page for Baxter International news (Ticker: BAX), a resource for investors and traders seeking the latest updates and insights on Baxter International stock.

Baxter International Inc. (NYSE: BAX) is a global healthcare company dedicated to providing essential renal and hospital products. With a comprehensive portfolio that includes home, acute, and in-center dialysis, sterile IV solutions, infusion systems and devices, parenteral nutrition, biosurgery products, anesthetics, and pharmacy automation, Baxter plays a critical role in expanding access to healthcare worldwide.

Baxter's recent acquisition of Hillrom in late 2021 has significantly enhanced its hospital-focused offerings. This acquisition brought basic equipment like hospital beds under Baxter’s umbrella, along with advanced digital solutions such as smart beds and the Voalte medical communications app. These additions complement Baxter’s legacy operations, which focus on products for patients with acute and chronic kidney failure. Notably, Baxter plans to spin off its renal care segment by mid-2024.

Additionally, Baxter provides a variety of injectable therapies, including IV pumps, administrative sets, and nutritional products, as well as surgical sealants and hemostatic agents used in various care settings. The company’s extensive global footprint and the essential nature of its products and services underscore its commitment to advancing healthcare innovations and improving patient care in both emerging and developed markets.

Baxter’s financial condition remains robust, bolstered by its continuous innovation and strategic partnerships. The company’s employees worldwide are dedicated to building upon a rich heritage of medical breakthroughs, ensuring that Baxter continues to be at the forefront of healthcare advancements.

Rhea-AI Summary
Baxter International Inc. (NYSE:BAX) launches PERCLOT Absorbable Hemostatic Powder in the U.S. market, expanding its hemostatic product portfolio. PERCLOT is a passive, absorbable hemostatic powder designed for patients with intact coagulation to address mild bleeding, enhancing surgical care and reducing the need for blood transfusions. The product rapidly absorbs water, forming a gelled adhesive matrix that provides a mechanical barrier against further bleeding. The launch aims to optimize patient care and reduce the total cost of care by addressing a broader range of intraoperative bleeding.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.58%
Tags
none
-
News
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.7%
Tags
dividends
-
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.92%
Tags
management
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.84%
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.73%
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.05%
Tags
conferences earnings
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.85%
Tags
conferences
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.39%
Tags
none
-
News
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-5.55%
Tags
none
Rhea-AI Summary
Baxter International Inc. has signed an agreement to divest its BioPharma Solutions business to Advent International and Warburg Pincus for $4.25 billion in cash. The transaction is expected to close in the second half of 2023. Baxter plans to use the proceeds to reduce its debt. The divestiture will establish a standalone contract development and manufacturing organization (CDMO) platform. BPS is expected to generate revenues of approximately $600 million in 2023.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.96%
Tags
none

FAQ

What is the current stock price of Baxter International (BAX)?

The current stock price of Baxter International (BAX) is $33.21 as of November 22, 2024.

What is the market cap of Baxter International (BAX)?

The market cap of Baxter International (BAX) is approximately 16.8B.

What does Baxter International Inc. specialize in?

Baxter specializes in essential renal and hospital products, including dialysis, sterile IV solutions, infusion systems, parenteral nutrition, biosurgery products, anesthetics, and pharmacy automation.

What was the impact of Baxter's acquisition of Hillrom?

The acquisition of Hillrom in late 2021 enhanced Baxter's hospital-focused offerings with additional equipment like hospital beds and digital solutions such as smart beds and the Voalte medical communications app.

What products does Baxter offer for kidney failure patients?

Baxter provides tools for patients with acute and chronic kidney failure, including home, acute, and in-center dialysis solutions.

What are some of Baxter's injectable therapies?

Baxter offers a range of injectable therapies, including IV pumps, administrative sets, and nutritional products.

What surgical products does Baxter provide?

Baxter provides surgical sealants and hemostatic agents used in various care settings.

What is Baxter's plan for its renal care segment?

Baxter plans to spin off its renal care segment by mid-2024.

How does Baxter contribute to global healthcare access?

Baxter’s global footprint and essential products play a key role in expanding access to healthcare in both emerging and developed countries.

How does Baxter ensure continuous innovation?

Baxter builds upon a rich heritage of medical breakthroughs and strategically partners to advance the next generation of healthcare innovations.

What are some of the digital solutions offered by Baxter?

Baxter offers digital solutions like smart beds and the Voalte medical communications app, acquired through Hillrom.

What is Baxter's commitment to patient care?

Baxter is committed to improving patient care by providing essential medical products, fostering healthcare innovations, and maintaining a robust financial condition.

Baxter International Inc.

NYSE:BAX

BAX Rankings

BAX Stock Data

16.78B
508.41M
0.38%
94.45%
2.25%
Medical Instruments & Supplies
Surgical & Medical Instruments & Apparatus
Link
United States of America
DEERFIELD